Omics! Omics!

Another edition of my dabbling with AI.  Somewhat like what I reported before - a customer asked if Ginkgo Cloud Lab's Echo-MS option ...

Vibe coding - solving problems by extended conversation with a machine learning program rather than writing the code yourself - is all the r...

The liquid biopsy space continues to grow and heat up - just this week Roche's Foundation Medicine unit announced the acquisition of Min...

AGBT Agriculture was a really nice meeting - lovely venue in the Arizona desert, a meeting size that you felt you could (but weren't com...

I'm headed over to AGBT Agriculture tomorrow, after getting to Phoenix ahead of time to check out some sights.  The Desert Botanical Gar...

About a year ago we took a family vacation to the Netherlands with a prime goal to see tulips - and tulips we did see!  Even a rainy day (wh...

I've loved the n6tec icon96 instrument since they first tipped me about it several years back.  The idea of running 96 independent PCRs ...

After Roche's AGBT presentation, a key question for many is "who is going to buy an Axelios?".  Below are some thoughts on the...

In my current role I spend a lot of time on LinkedIn. A core task is to identify possible customers, and LinkedIn is rich hunting ground. I...

Even before new CEO Francis Van Parys took the reins at Oxford Nanopore with the start of the month, the company had made yet another primin...

By far the most awaited news at AGBT was Roche's reveal of the pricing scheme for Axelios 1 consumables: what would be the structure and...

A bit of interesting news during AGBT was the announcement of the sale of Complete Genomics to Swiss Rockets, a Basel-based company which ha...

Ultima Genomics announced the 2.0 version of their Solaris chemistry at AGBT.  Perhaps the biggest splash here is that Solaris 2.0 relies on...

On the Thursday before AGBT, Element Biosciences unveiled their VITARI high throughput sequencer, expected to ship in the second half of thi...

Illumina is rebranding their Constellation mapped read technology to TruPath Genome and launching it into the marketplace. Priced at $395 pe...

Canal Biosciences is a small startup in the library prep space that is making a debut at AGBT this year as a contributing sponsor.  Based in...

AGBT is another conference with a wonderful wealth of scientific posters and never enough time to view them all properly. I definitely enjoy...

When I started this space, I vowed not to become just a mouthpiece of my employer - but when my employer does something interesting, of cour...

AGBT starts on Monday at the Signia by Hilton Bonnet Creek in Orlando on Monday, but the pre-conference flurry of announcements is already r...

Single cell RNA sequencing is nearly ubiquitous; single cell DNA sequencing has been much rarer.  I'm going to dive in a bit - but not a...